Cargando…

HER3 Alterations in Cancer and Potential Clinical Implications

SIMPLE SUMMARY: HER3 is a member of the HER family. In the past decade, HER3 has been recognized as an important protein in allowing tumors to grow unchecked. This review focuses on HER3′s involvement in bladder, breast, colorectal, and lung cancers. In addition, this review covers what is known abo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kilroy, Mary Kate, Park, SoYoung, Feroz, Wasim, Patel, Hima, Mishra, Rosalin, Alanazi, Samar, Garrett, Joan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776947/ https://www.ncbi.nlm.nih.gov/pubmed/36551663 http://dx.doi.org/10.3390/cancers14246174

Ejemplares similares

HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers
por: Alanazi, Samar M., et al.
Publicado: (2023)

PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
por: Mishra, Rosalin, et al.
Publicado: (2021)

IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
por: Patel, Hima, et al.
Publicado: (2021)

HER3 signaling and targeted therapy in cancer
por: Mishra, Rosalin, et al.
Publicado: (2018)

BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dependence on Increased Antioxidant SOD2 and Increased Reactive Oxygen Species Levels
por: Yuan, Long, et al.
Publicado: (2020)

Current Advances in the Treatment of BRAF-Mutant Melanoma
por: Patel, Hima, et al.
Publicado: (2020)

Activating HER3 mutations in breast cancer
por: Mishra, Rosalin, et al.
Publicado: (2018)

Genomic alterations of ERBB receptors in cancer: clinical implications
por: Mishra, Rosalin, et al.
Publicado: (2017)

Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth
por: Mishra, Rosalin, et al.
Publicado: (2021)

RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells
por: Patel, Hima, et al.
Publicado: (2023)

Utilization of Reactive Oxygen Species Targeted Therapy to Prolong the Efficacy of BRAF Inhibitors in Melanoma
por: Yuan, Long, et al.
Publicado: (2018)

Association of HER1 and HER2 Gene Variants in the Predisposition of Colorectal Cancer
por: Alanazi, Ibrahim O., et al.
Publicado: (2021)

Can antioxidants be effective therapeutics for type 2 diabetes?
por: Park, Soyoung, et al.
Publicado: (2020)

The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2017)

Microcirculatory alterations: potential mechanisms and implications for therapy
por: De Backer, Daniel, et al.
Publicado: (2011)

Therapeutic implication of HER2 in advanced biliary tract cancer
por: Nam, Ah-Rong, et al.
Publicado: (2016)

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
por: Mota, Jose Mauricio, et al.
Publicado: (2017)

Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects
por: Ishiyama, Noboru, et al.
Publicado: (2023)

Prognostic implications of HER2 heterogeneity in gastric cancer
por: Motoshima, Shigenobu, et al.
Publicado: (2018)

An eye for a lost eye: A case of self-inflicting gunshot injury
por: Kar, Indu Bhusan, et al.
Publicado: (2014)

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer
por: Gaibar, Maria, et al.
Publicado: (2020)

Epigenetic Alterations in Bladder Cancer and Their Potential Clinical Implications
por: Han, Han, et al.
Publicado: (2012)

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
por: Kim, S T, et al.
Publicado: (2018)

The Potential of panHER Inhibition in Cancer
por: Wang, Xiaochun, et al.
Publicado: (2015)

Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017)

The Brain-Gut-Microbiome System: Pathways and Implications for Autism Spectrum Disorder
por: Chernikova, Michelle A., et al.
Publicado: (2021)

Participation in Sports Activities before and after the Outbreak of COVID-19: Analysis of Data from the 2020 Korea National Sports Participation Survey
por: Lee, On, et al.
Publicado: (2022)

Expression of Septin 2 and Her2/neu in Colorectal Cancer
por: Hanbuli, Hala M. El, et al.
Publicado: (2021)

Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer
por: Collins, Denis M., et al.
Publicado: (2019)

Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis
por: Zhou, Chenfei, et al.
Publicado: (2018)

Blockchain as a Service
por: Kilroy, Karen
Publicado: (2019)

AI and the Law
por: Kilroy, Karen
Publicado: (2021)

The structure–function relationships and physiological roles of MnSOD mutants
por: Bonetta Valentino, Rosalin
Publicado: (2022)

Novel agents that downregulate EGFR, HER2, and HER3 in parallel
por: Ferreira, Renan Barroso, et al.
Publicado: (2015)

Development and Function of the Intestinal Microbiome and Potential Implications for Pig Production
por: Nowland, Tanya L., et al.
Publicado: (2019)

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer
por: Castagnoli, L, et al.
Publicado: (2017)

Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model
por: Chakraborty, Goutam, et al.
Publicado: (2012)

Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer
por: Zhang, Shu, et al.
Publicado: (2016)

Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma
por: Qiu, Miao‐Zhen, et al.
Publicado: (2021)

Therapeutic potential of HERS spheroids in tooth regeneration
por: Duan, Yufeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8sjsh62015hahfqc6gi4miba86